Bone mineral apparent density in juvenile dermatomyositis: the role of lean body mass and glucocorticoid use

References

• Cassidy J. T. Osteopenia and osteoporosis in children. Clin Exp Rheumatol 1999; 17: 245–50
   PubMedGoogle Scholar
• Perez M. D., Abrams S. A., Koenning G., Stuff J. E., O'Brien K. O., Ellis K. J. Mineral metabolism in children with dermatomyositis. J Rheumatol 1994; 21: 2364–9
   PubMedGoogle Scholar
• Pepmueller P. H., Cassidy J. T., Allen S. H., Hillman L. S. Bone mineralization and bone mineral metabolism in children with juvenile rheumatoid arthritis. Arthritis Rheum 1996; 39: 746–57
   PubMed Web of Science ®Google Scholar
• Pereira R. M. R., Corrente J. E., Chahade W., Yoshinari N. H. Evaluation by dual X‐ray absorptiometry (DXA) of bone mineral density in children with juvenile chronic arthritis. Clin Exp Rheumatol 1998; 16: 495–501
   PubMedGoogle Scholar
• Lien G., Selvaag A. M., Flato B., Haugen M., Vinje O., Sorskaar D., et al. A two‐year prospective controlled study of bone mass and bone turnover in children with early juvenile idiopathic arthritis. Arthritis Rheum 2005; 52: 833–40
   PubMed Web of Science ®Google Scholar
• Khan A. A., Bachrach L., Brown J. P., Hanley D. A., Josse R. G., Kendler D. L., et al. Standards and guidelines for performing central dual‐energy X‐ray absorptiometry in premenopausal women, men, and children. J Clin Densitom 2004; 51–63
   PubMedGoogle Scholar
• Genant H. K., Engelke K., Fuerst T., Gluer C. C., Grampp S., Harris S. T., et al. Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res 1996; 11: 707–30
   PubMed Web of Science ®Google Scholar
• Brambilla P., Rolland‐Cachera M. F., Testolin C., Briend A., Salvatoni A., Testolin G., et al. Lean mass of children in various nutritional states. Comparison between dual‐energy X‐ray absorptiometry and anthropometry. Ann N Y Acad Sci 2000; 904: 433–6
   PubMedGoogle Scholar
• Kipen Y., Strauss J. G., Morand E. F. Body composition in systemic lupus erythematosus. Br J Rheumatol 1998; 37: 514–19
   PubMedGoogle Scholar
• Carter D. R., Bouxsein M. L., Marcus R. New approaches for interpreting projected bone densitometry data. J Bone Miner Res 1992; 7: 137–45
   PubMed Web of Science ®Google Scholar
• Bohan A., Peter J. B. Polymyositis and dermatomyositis. N Engl J Med 1975; 292: 344–7
   PubMed Web of Science ®Google Scholar
• Tanner J. M. Blackwell Scientific Publications, Oxford 1962, Growth at adolescence, 2nd edn
   Google Scholar
• Bode R. K., Klein‐Gitelman M. S., Miller M. L., Lechman T. S., Pachman L. M. Disease activity scores for children with juvenile dermatomyositis: reliability and validity evidence. Arthritis Rheum 2003; 49: 7–15
   PubMed Web of Science ®Google Scholar
• Lovell D. J., Lindsley C. B., Rennebohm R. M., Ballinger S. H., Bowyer S. L., Giannini E. H., et al. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum 1999; 42: 2213–19
   PubMedGoogle Scholar
• Florence J. M., Pandya S., King W. M., Robison J. D., Baty J., Miller J. P., et al. Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne's muscular dystrophy. Phys Ther 1992; 72: 115–22
   PubMed Web of Science ®Google Scholar
• Bezerra M. C., Calomeni G. D., Caparbo V. F., Gebrim E. S., Rocha M. S., Pereira R. M. R. Low bone density and low serum levels of soluble RANK ligand are associated with severe arterial calcification in patients with Takayasu arteritis. Rheumatology 2005; 44: 1503–6
   PubMedGoogle Scholar
• Taylor A., Konrad P. T., Norman M. E., Harcke H. T. Total body bone mineral density in young children: influence of head bone mineral density. J Bone Miner Res 1997; 12: 652–5
   PubMedGoogle Scholar
• Crabtree N. J., Leonard M. B., Zemel B. S. Dual‐energy x‐ray absorptiometry. Bone densitometry in growing patients: guidelines for clinical practice, A. J Sawyer, L. K Bachrach, E. B Fung. Humana Press Inc, Totowa, NJ 2007; 41–57
   Google Scholar
• Cvijetic S., Korsic M. Apparent bone mineral density estimated from DXA in healthy men and women. Osteoporos Int 2004; 15: 295–300
   PubMedGoogle Scholar
• Stewart W. A., Acott P. D., Salisbury S. R., Lang B. A. Bone mineral density in juvenile dermatomyositis. Arthritis Rheum 2003; 48: 2294–8
   PubMedGoogle Scholar
• Alsufyani K. A., Ortiz‐Alvarez O., Cabral D. A., Tucker L. B., Petty R. E., Nadel H., et al. Bone mineral density in children and adolescents with systemic lupus erythematosus, juvenile dermatomyositis and systemic vasculitis: relationship to disease duration, cumulative corticosteroid dose, calcium intake and exercise. J Rheumatol 2005; 32: 729–33
   PubMedGoogle Scholar
• Castro T. C. M., Terreri M. T. R. A., Szejnfeld V. L., Len C., Fonseca A. S. M., Hilário M. O. E. Bone mineral density of Brazilian girls with juvenile dermatomyositis. Braz J Med Biol Res 2005; 38: 309–13
   PubMedGoogle Scholar
• Bachrach L. K., Hastie T., Wang M. C., Narasimhan B., Marcus R. Bone mineral acquisition in healthy Asian, Hispanic, Black, and Caucasian youth: a longitudinal study. J Clin Endocrinol Metab 1999; 84: 4702–12
   PubMed Web of Science ®Google Scholar
• Wang M. C., Aguirre M., Bhudhikanok G. S., Kendall C. G., Kirsch S., Marcus R., et al. Bone mass and hip axis length in healthy Asian, black, Hispanic, and white American youths. J Bone Miner Res 1997; 12: 1922–35
   PubMedGoogle Scholar
• Bezerra M. C., Carvalho J. F., Prokopowitsch A. S., Pereira R. M. R. RANK, RANKL and osteoprotegerin in arthritis bone loss. Braz J Med Biol Res 2005; 38: 161–70
   PubMed Web of Science ®Google Scholar
• Kong Y. Y., Boyle W. J., Penninger J. M. Osteoprotegerin ligand: a regulator of immune responses and bone physiology. Immunol Today 2000; 21: 495–502
   PubMedGoogle Scholar
• Mackiewicz Z., Hukkanen M., Povilenaite D., Sukura A., Fonseca J. E., Virtanen I., et al. Dual effects of caspase‐1, interleukin‐1 beta, tumour necrosis factor‐alpha and nerve growth factor receptor in inflammatory myopathies. Clin Exp Rheumatol 2003; 21: 41–8
   PubMedGoogle Scholar
• Salomonsson S., Lundberg I. E. Cytokines in idiopathic inflammatory myopathies. Autoimmunity 2006; 39: 117–90
   Google Scholar
• Hofbauer L. C., Schoppet M. Clinical implications of osteoprotegerin/RANKL/RANK system for bone and vascular diseases. J Am Med Assoc 2004; 292: 490–5
   PubMed Web of Science ®Google Scholar
• Rouster‐Stevens K. A., Langman C. B., Price H. E., Seshadri R., Shore R. M., Abbott K., Patchman L. M. RANK: osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis. Arthritis Rheum 2007; 56: 977–83
   PubMedGoogle Scholar
• Haugen M., Lien G., Flato B., Kvammen J., Vinje O., Sorskaar D., et al. Young adults with juvenile arthritis in remission attain normal peak bone mass at lumbar spine and forearm. Arthritis Rheum 2000; 43: 1504–10
   PubMedGoogle Scholar
• Haugeberg G., Griffiths B., Sokoll K. B., Emery P. Bone loss in patients treated with pulses of methylprednisolone is not negligible: a short term prospective observational study. Ann Rheum Dis 2004; 63: 940–4
   PubMed Web of Science ®Google Scholar
• Bonjour J P., Theintz G., Buchs B., Slosman D., Rizzoli R. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab 1991; 73: 555–63
   PubMedGoogle Scholar
• Theintz G., Buchs B., Rizzoli R., Slosman D., Clavien H., Sizonenko P. C., et al. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab 1992; 75: 1060–65
   PubMed Web of Science ®Google Scholar
• Kotaniemi A., Savolainen A., Kroger H., Kautiainen H., Isomaki H. Weight‐bearing physical activity, calcium intake, systemic glucocorticoid, chronic inflammation and body constitution as determinants of lumbar and femoral bone mineral in juvenile chronic arthritis. Scand J Rheumatol 1999; 28: 19–26
   PubMed Web of Science ®Google Scholar
• Reid I. R. Relationships among body mass, its components, and bone. Bone 2002; 31: 547–55
   PubMed Web of Science ®Google Scholar
• Lim S., Joung H., Shin C. S., Lee H. K., Kim K. S., Shin E. K., et al. Body composition changes with age have gender‐specific impacts on bone mineral density. Bone 2004; 35: 792–8
   PubMed Web of Science ®Google Scholar
• Mul D., van Suijlekom‐Smit L. W. A., ten Cate R., Bekkering W. P., de Muinck Keizer‐Schrama S. M. Bone mineral density and body composition and influencing factors in children with rheumatic diseases treated with corticosteroids. J Pediatr Endocrinol Metab 2002; 15: 187–92
   PubMedGoogle Scholar
• Rebuffe‐Scrive M., Krotkiewski M., Elfverson J., Bjorntorp P. Muscle and adipose tissue morphology and metabolism in Cushing's syndrome. J Clin Endocrinol Metab 1998; 67: 1122–8
   Google Scholar